ISRG250103C495000
- 0.00
- 0.000.00%
Intuitive Surgical Newsroom
Bernstein Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $650
Bernstein Sticks to Its Buy Rating for Intuitive Surgical (ISRG)
RBC Capital Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $611
UBS Raises Price Target on Intuitive Surgical to $560 From $500, Keeps Neutral Rating
Evercore Maintains Intuitive Surgical(ISRG.US) With Hold Rating, Raises Target Price to $530
CICC Initiates Intuitive Surgical at Neutral With $550 Price Target
RBC Capital Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $611
Intuitive Surgical Analyst Ratings
Truist Financial Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Announces Target Price $640
RBC Capital Adjusts Intuitive Surgical Price Target to $611 From $555, Maintains Outperform Rating
Mizuho Securities Maintains Intuitive Surgical(ISRG.US) With Hold Rating, Raises Target Price to $570
Bernstein Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $650
Wells Fargo Raises Price Target on Intuitive Surgical to $630 From $549, Keeps Overweight Rating
Intuitive Surgical Analyst Ratings
Citi Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $640
Wells Fargo Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $630
Stifel Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $610
Intuitive Surgical Is Maintained at Buy by Stifel
Intuitive Surgical Analyst Ratings
Morgan Stanley Initiates Intuitive Surgical(ISRG.US) With Buy Rating, Announces Target Price $650